Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored [Seeking Alpha]
Liquidia Corporation (LQDA)
Last liquidia corporation earnings: 3/11 07:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
LQDA's Yutrepia demonstrates superior tolerability, higher achievable dosing, and rapid titration versus Tyvaso, driving robust commercial uptake and market share gains. Key binary risk centers on the imminent IP litigation outcome versus United Therapeutics; multiple scenarios could impact valuation, but commercial momentum is strong. Q3 results showed $51.7M net sales, positive EBITDA, and rapid prescriber adoption; pipeline asset L606 and global pivotal studies represent further upside catalysts. This idea was discussed in more depth with members of my private investing community, ROTY Biotech Community. Learn More » ALIOUI Mohammed Elamine/iStock via Getty Images Shares of pulmonary disease specialist Liquidia Corporation ( LQDA ) have risen by +180% over the past year and +450% over the past three years. As a top holding in our Core Biotech portfolio (emphasis in More on my IG service Take a 2 Week Free Trial and Join 500+ biotech investors and traders in ROTY Bi
Show less
Read more
Impact Snapshot
Event Time:
LQDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LQDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LQDA alerts
High impacting Liquidia Corporation news events
Weekly update
A roundup of the hottest topics
LQDA
News
- Laughing Water Capital's Updates on Liquidia Corp (LQDA) [Yahoo! Finance]Yahoo! Finance
- Liquidia (NASDAQ:LQDA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Liquidia: Won Many Patent Battles But The War Is Not Yet Won [Seeking Alpha]Seeking Alpha
- Laughing Water Capital Q4 2025 Letter [Seeking Alpha]Seeking Alpha
- Liquidia (NASDAQ:LQDA) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..MarketBeat
LQDA
Earnings
- 11/3/25 - Beat
LQDA
Sec Filings
- 1/13/26 - Form 4
- 1/13/26 - Form 4
- 1/13/26 - Form 4
- LQDA's page on the SEC website